These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 36109163)
1. Beyond borders: cystic fibrosis survival between Australia, Canada, France and New Zealand. Coriati A; Ma X; Sykes J; Stanojevic S; Ruseckaite R; Lemonnier L; Dehillotte C; Tate J; Byrnes CA; Bell SC; Burgel PR; Stephenson AL Thorax; 2023 Mar; 78(3):242-248. PubMed ID: 36109163 [TBL] [Abstract][Full Text] [Related]
2. Impact of a high emergency lung transplantation programme for cystic fibrosis in France: insight from a comparison with Canada. Coriati A; Sykes J; Lemonnier L; Ma X; Stanojevic S; Dehillotte C; Carlier N; Stephenson AL; Burgel PR Eur Respir J; 2022 Jan; 59(1):. PubMed ID: 34140297 [TBL] [Abstract][Full Text] [Related]
3. Daily hemodialysis practices in Australia/New Zealand and in France: a comparative cohort study. Pladys A; Bayat S; Couchoud C; Vigneau C; McDonald S BMC Nephrol; 2019 May; 20(1):156. PubMed ID: 31064344 [TBL] [Abstract][Full Text] [Related]
4. Survival Comparison of Patients With Cystic Fibrosis in Canada and the United States: A Population-Based Cohort Study. Stephenson AL; Sykes J; Stanojevic S; Quon BS; Marshall BC; Petren K; Ostrenga J; Fink AK; Elbert A; Goss CH Ann Intern Med; 2017 Apr; 166(8):537-546. PubMed ID: 28288488 [TBL] [Abstract][Full Text] [Related]
5. Survival and Lung Transplant Outcomes for Individuals With Advanced Cystic Fibrosis Lung Disease Living in the United States and Canada: An Analysis of National Registries. Ramos KJ; Sykes J; Stanojevic S; Ma X; Ostrenga JS; Fink A; Quon BS; Marshall BC; Faro A; Petren K; Elbert A; Goss CH; Stephenson AL Chest; 2021 Sep; 160(3):843-853. PubMed ID: 33878343 [TBL] [Abstract][Full Text] [Related]
6. Survival of people with cystic fibrosis in Australia. Ruseckaite R; Salimi F; Earnest A; Bell SC; Douglas T; Frayman K; Keatley L; King S; Kotsimbos T; Middleton PG; Morey S; Mulrennan S; Schultz A; Wainwright C; Ward N; Wark P; Ahern S Sci Rep; 2022 Nov; 12(1):19748. PubMed ID: 36396972 [TBL] [Abstract][Full Text] [Related]
7. Survival estimates in European cystic fibrosis patients and the impact of socioeconomic factors: a retrospective registry cohort study. McKone EF; Ariti C; Jackson A; Zolin A; Carr SB; Orenti A; van Rens JG; Lemonnier L; Macek M; Keogh RH; Naehrlich L; ; Eur Respir J; 2021 Sep; 58(3):. PubMed ID: 33678607 [TBL] [Abstract][Full Text] [Related]
8. Case-mix adjustment for evaluation of mortality in cystic fibrosis. O'Connor GT; Quinton HB; Kahn R; Robichaud P; Maddock J; Lever T; Detzer M; Brooks JG; Pediatr Pulmonol; 2002 Feb; 33(2):99-105. PubMed ID: 11802245 [TBL] [Abstract][Full Text] [Related]
9. A contemporary survival analysis of individuals with cystic fibrosis: a cohort study. Stephenson AL; Tom M; Berthiaume Y; Singer LG; Aaron SD; Whitmore GA; Stanojevic S Eur Respir J; 2015 Mar; 45(3):670-9. PubMed ID: 25395034 [TBL] [Abstract][Full Text] [Related]
11. Gender differences in outcomes of patients with cystic fibrosis. Harness-Brumley CL; Elliott AC; Rosenbluth DB; Raghavan D; Jain R J Womens Health (Larchmt); 2014 Dec; 23(12):1012-20. PubMed ID: 25495366 [TBL] [Abstract][Full Text] [Related]
12. Patient survival on haemodiafiltration and haemodialysis: a cohort study using the Australia and New Zealand Dialysis and Transplant Registry. See EJ; Hedley J; Agar JWM; Hawley CM; Johnson DW; Kelly PJ; Lee VW; Mac K; Polkinghorne KR; Rabindranath KS; Sud K; Webster AC Nephrol Dial Transplant; 2019 Feb; 34(2):326-338. PubMed ID: 30124954 [TBL] [Abstract][Full Text] [Related]
13. Clinical Characteristics and Predictors of Reduced Survival for Adult-diagnosed Cystic Fibrosis. Analysis of the Canadian CF Registry. Desai S; Wong H; Sykes J; Stephenson AL; Singer J; Quon BS Ann Am Thorac Soc; 2018 Oct; 15(10):1177-1185. PubMed ID: 29944384 [TBL] [Abstract][Full Text] [Related]
15. Survival of recipients of cadaveric kidney transplants compared with those receiving dialysis treatment in Australia and New Zealand, 1991-2001. McDonald SP; Russ GR Nephrol Dial Transplant; 2002 Dec; 17(12):2212-9. PubMed ID: 12454235 [TBL] [Abstract][Full Text] [Related]
16. Heterogeneity in Survival in Adult Patients With Cystic Fibrosis With FEV Ramos KJ; Quon BS; Heltshe SL; Mayer-Hamblett N; Lease ED; Aitken ML; Weiss NS; Goss CH Chest; 2017 Jun; 151(6):1320-1328. PubMed ID: 28115168 [TBL] [Abstract][Full Text] [Related]
17. Lessons for a national pharmaceuticals strategy in Canada from Australia and New Zealand. LeLorier J; Rawson NS Can J Cardiol; 2007 Jul; 23(9):711-8. PubMed ID: 17622393 [TBL] [Abstract][Full Text] [Related]
18. Changing survival of people with myeloma and end stage kidney disease: A cohort study using Australian and New Zealand dialysis and transplant registry 1963-2013. Webster AC; Irish AB; Kelly PJ Nephrology (Carlton); 2018 Mar; 23(3):217-225. PubMed ID: 28004444 [TBL] [Abstract][Full Text] [Related]
19. Exploring the burden of fatal drowning and data characteristics in three high income countries: Australia, Canada and New Zealand. Peden AE; Franklin RC; Clemens T BMC Public Health; 2019 Jun; 19(1):794. PubMed ID: 31226973 [TBL] [Abstract][Full Text] [Related]
20. Clinical and demographic factors associated with post-lung transplantation survival in individuals with cystic fibrosis. Stephenson AL; Sykes J; Berthiaume Y; Singer LG; Aaron SD; Whitmore GA; Stanojevic S J Heart Lung Transplant; 2015 Sep; 34(9):1139-45. PubMed ID: 26087666 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]